Podcast
 |
| On this edition of The Burrill Report: Jim Greenwood, president and CEO of the Biotechnology Industry Organization, discusses the uncertainty surrounding healthcare reform, what it means for issues such as follow-on biologics, and what the industry's policy agenda looks like for 2010. |
G. Steven Burrill
Welcome from the CEO
Flash required to view this video. Download the latest version here
G. Steven BurrillNews
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech Closes the Year on an Upswing January 04, 2010 | Press Release
Biotech gets back on track in November December 01, 2009 | Press Release
See all News
Burrill Venture CapitalBurrill's venture funds capitalize on our unique investment platform, the opportunities created by today’s technologic revolution, and capital market inefficiency.  Learn more about Burrill Venture Capital | Burrill Private EquityOur private equity team focuses on undervalued small/midcap public companies and selected buy-outs and spin-outs.  Learn more about Burrill Private Equity | Burrill Merchant BankingBurrill Merchant Banking assists life science companies identify, negotiate and close strategic partnerships, M&A transactions and financings.  Learn more about Burrill Merchant Banking | ||
Burrill InternationalBurrill & Company has established a multicultural and multilingual team, with extensive international business experience, to bridge the different regions of the world.  Learn more about Burrill International | Burrill Publications & ResourcesJUST PUBLISHED: Buy a single issue or subscribe  Get access now | Burrill Conferences & Special EventsThe Burrill Consumer
Burrill Conferences & Special Events | ||
